ORGN · As filed with the SEC

Origin Materials balance sheet, by quarter

The statement as Origin Materials presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONDENSED CONSOLIDATED BALANCE SHEETS · USD thousands

USD thousands	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024
ASSETS
Current assets
Cash and cash equivalents	19,191	32,923	34,061	35,295	43,835	56,307	56,396	55,684
Marketable securities	13,457	20,545	20,279	34,106	39,213	46,613	56,996	76,461
Accounts receivable net of allowance for credit losses of $5,448 and $828, respectively	5,362	13,049	15,534	17,888	19,120	19,179	17,919	15,460
Other receivables	1,587	2,101	2,456	2,661	3,106	2,526	5,183	4,554
Inventory	682	684	635	687	866	866	990	1,057
Prepaid expenses and other current assets	1,126	2,448	2,045	1,833	2,087	2,401	3,909	8,172
Land held for sale	9,125	9,126	9,125	9,114	11,282	11,282	—	—
Total current assets	50,530	80,876	84,135	101,584	119,509	139,174	141,393	161,388
Property, plant, and equipment, net	79,726	72,852	225,744	229,068	211,568	203,919	222,758	233,561
Operating lease right-of-use asset	3,080	3,149	3,270	3,357	3,437	3,735	3,829	4,184
Intangible assets, net	24	32	51	60	65	73	88	97
Deferred tax assets	—	0	410	496	563	621	860	1,073
Other long-term assets	1,715	751	13,735	13,812	13,835	30,505	30,627	30,679
Total assets	135,075	157,660	327,345	348,377	348,977	378,027	399,555	430,982
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	1,331	3,568	1,922	2,083	3,176	2,921	1,308	1,849
Accrued expenses	4,717	4,947	8,917	11,351	6,922	2,779	3,161	3,349
Operating lease liabilities, current	316	306	331	336	334	323	305	305
Notes payable, short-term	4,450	4,511	1,730	1,730	1,730	3,772	3,772	5,303
Convertible notes, net of issuance costs	6,979	14,970	—	—	—	—	—	—
Other liabilities, current	1,231	231	387	441	410	2,754	93	1,085
Derivative liability	—	—	—	—	—	0	49	0
Total current liabilities	19,024	28,533	13,287	15,941	12,572	12,549	8,688	11,891
Earnout liability	24	24	24	24	24	2,486	4,184	1,243
Canadian Government Research and Development Program liability	16,496	16,776	14,876	15,132	14,422	14,399	15,309	15,133
Common stock warrants liability	89	167	518	681	1,788	4,566	4,254	1,969
Notes payable, long-term	7,654	4,386	0	1,730	1,730	1,730	1,730	3,459
Operating lease liabilities	3,449	3,533	3,612	3,689	3,770	3,858	3,944	4,043
Other liabilities, long-term	19	30	41	54	63	74	2,590	2,606
Total liabilities	46,755	53,449	32,358	37,251	34,369	39,662	40,699	40,344
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2026 and December 31, 2025	0	0	0	0	0	0	0	0
Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 5,499,307 and 5,173,884, issued and outstanding as of March 31, 2026 and December 31, 2025, respectively (including 50,000 and 50,000, respectively, of Sponsor Vesting Shares)	15	15	15	15	15	15	15	15
Additional paid-in capital	404,667	402,378	400,253	397,812	395,475	393,186	390,875	388,412
Accumulated deficit	(305,475)	(287,825)	(93,697)	(77,315)	(64,568)	(38,127)	(24,605)	12,158
Accumulated other comprehensive loss	(10,887)	(10,357)	(11,584)	(9,386)	(16,314)	(16,709)	(7,429)	(9,947)
Total stockholders’ equity	88,320	104,211	294,987	311,126	314,608	338,365	358,856	390,638
Total liabilities and stockholders’ equity	135,075	157,660	327,345	348,377	348,977	378,027	399,555	430,982
Sponsor vesting shares issued (in shares)	—	—	—	—	—	—	3,000,000	—
Sponsor vesting shares outstanding (in shares)	—	—	—	—	—	—	3,000,000	—

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.